Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Lymph-targeted antitumor mitomycin C conjugate prepared at Chinese university

Feb. 7, 2000

Kyowa Hakko presents antitumor agents interacting with farnesyltransferase

Feb. 7, 2000

New antisense oligonucleotides targeting human SMAD3 from Isis

Feb. 7, 2000

Antitumor epothilone derivatives reported in patent literature by Schering AG

Feb. 4, 2000

COX-2 inhibitor now available for FAP indication

Feb. 4, 2000

Bexarotene now on the market in U.S.

Feb. 4, 2000

InKine files patent for novel antiangiogenic protein

Feb. 4, 2000

AEterna to commence phase III trial of AE-941 in second cancer indication

Feb. 4, 2000

Atrix reports progress in Atrigel leuprolide formulations

Feb. 4, 2000

Incyte patents novel GFMOs for cancer and fibrotic disorders

Feb. 3, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026